Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nutrien Ltd T.NTR

Alternate Symbol(s):  NTR

Nutrien Ltd. is a Canada-based company, which is a provider of crop inputs and services. The Company operates through four segments: Nutrien Ag Solutions (Retail), Potash, Nitrogen and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds and merchandise, and it provides services directly to growers through a network of farm centers in North America, South America and Australia. Its Retail business includes Nutrien Ag Solutions and Landmark Retail businesses, which provide agricultural solutions, including nutrients, crop protection products, seed, services and agronomic advice to growers. The Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrients contained in the products that it produces. The Company produces and distributes over 27 million tons of potash, nitrogen and phosphate products for agricultural, industrial and feed customers worldwide. It operates approximately 2,000 retail locations in over seven countries.


TSX:NTR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by retiredcfon May 08, 2024 1:21pm
106 Views
Post# 36029311

TD

TDCurrently have a US$67.00 target. GLTA

UPDATE AND Q1/24 PREVIEW

THE TD COWEN INSIGHT

Looking ahead, we see several positives for NTR in 2024, including stronger potash and nitrogen sales volumes (supported by improved demand, and higher nitrogen production operating rates), and rebound in Retail's results (we expect less margin pressure). Meanwhile, despite some recent volatility, we see potential for a general improvement in various nutrient prices as 2024 progresses.

Event

Nutrien will report Q1/24 results on May 8 (after market close). Conference call at 10:00 a.m. ET on May 9 (1-800-717-1738).

Impact: NEUTRAL

We forecast Q1/24 adjusted EBITDA of $965mm; in line with consensus of $981mm. Our forecast calls for adjusted EBITDA to decline 32% y/y. As in recent quarters, we expect the y/y decline in adjusted EBITDA to be driven by lower fertilizer prices (prior-year comp still difficult). That said, we expect all three of NTR's wholesale segments to see positive y/y sales volume growth in Q1/24 (consistent with what was observed in Q4/23), while we also expect the Retail segment's adj. EBITDA to show y/y improvement (although we note that Q1 is a seasonally weak quarter for Retail).

Fertilizer Price Update: Fertilizer price performance since late-February 2024 (when NTR reported Q4/23 results) has been mixed (although price pressures have been more prevalent than price increases). Although both held in well through much of March, Midwest potash and NOLA urea have been two of the weakest performers since late- February 2024 (-10% and -16%, respectively, as a result of more recent price declines). By comparison, Tampa ammonia and phosphate prices have been relatively steady in recent months, while Brazil potash stands out as one of the few key benchmark nutrients to have seen price appreciation of-late (+10% since late-February).

Updated Estimates: We have made various adjustments to our forecasts, although on the whole, our consolidated estimates are not materially changed.

NTR's 2024 guidance/outlook will be a key area of focus when results are released, although perhaps not to the same degree as in the past, given NTR now provides guidance on fewer metrics. Our full-year 2024 adjusted EBITDA estimate of $5.589bln is in line with consensus of $5.597bln.


<< Previous
Bullboard Posts
Next >>